{"id":"https://openalex.org/W7204808590","doi":"https://doi.org/10.55262/fabadeczacilik.1812846","title":"MOLECULAR DOCKING-GUIDED COFORMER SELECTION AND COCRYSTALLIZATION FOR ENHANCED BIOPHARMACEUTICAL PERFORMANCE OF TOLVAPTAN","display_name":"MOLECULAR DOCKING-GUIDED COFORMER SELECTION AND COCRYSTALLIZATION FOR ENHANCED BIOPHARMACEUTICAL PERFORMANCE OF TOLVAPTAN","publication_year":2026,"publication_date":"2026-08-31","ids":{"openalex":"https://openalex.org/W7204808590","doi":"https://doi.org/10.55262/fabadeczacilik.1812846"},"language":"tr","primary_location":{"id":"doi:10.55262/fabadeczacilik.1812846","doi":"https://doi.org/10.55262/fabadeczacilik.1812846","is_oa":true,"landing_page_url":"https://doi.org/10.55262/fabadeczacilik.1812846","pdf_url":"https://dergipark.org.tr/en/download/article-file/5371759","source":{"id":"https://openalex.org/S4220650949","display_name":"Fabad Journal of Pharmaceutical Sciences","issn_l":"1300-4182","issn":["1300-4182"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fabad Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://dergipark.org.tr/en/download/article-file/5371759","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032650259","display_name":"Monika Nijhawan","orcid":"https://orcid.org/0000-0002-3564-0257","observed_orcids":["https://orcid.org/0000-0002-3564-0257"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Monika Nijhawan","raw_affiliation_strings":["gokaraju rangaraju college of pharmacy"],"raw_orcid":"https://orcid.org/0000-0002-3564-0257","affiliations":[{"raw_affiliation_string":"gokaraju rangaraju college of pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115973810","display_name":"Dedipya Goda Srivalli Vangala","orcid":"https://orcid.org/0009-0005-1405-475X","observed_orcids":["https://orcid.org/0009-0005-1405-475X"]},"institutions":[{"id":"https://openalex.org/I8975392","display_name":"Osmania University","ror":"https://ror.org/030sjb889","country_code":"IN","type":"education","lineage":["https://openalex.org/I8975392"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dedipya Goda Srivalli Vangala","raw_affiliation_strings":["Gokaraju Rangaraju College of Pharmacy"],"raw_orcid":"https://orcid.org/0009-0005-1405-475X","affiliations":[{"raw_affiliation_string":"Gokaraju Rangaraju College of Pharmacy","institution_ids":["https://openalex.org/I8975392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000183242","display_name":"Rajeswari Aleti","orcid":"https://orcid.org/0009-0001-8894-9063","observed_orcids":["https://orcid.org/0009-0001-8894-9063"]},"institutions":[{"id":"https://openalex.org/I8975392","display_name":"Osmania University","ror":"https://ror.org/030sjb889","country_code":"IN","type":"education","lineage":["https://openalex.org/I8975392"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajeswari Aleti","raw_affiliation_strings":["Gokaraju Rangaraju College of Pharmacy"],"raw_orcid":"https://orcid.org/0009-0001-8894-9063","affiliations":[{"raw_affiliation_string":"Gokaraju Rangaraju College of Pharmacy","institution_ids":["https://openalex.org/I8975392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083438409","display_name":"Sailaja Gunnam","orcid":"https://orcid.org/0009-0007-2550-4001","observed_orcids":["https://orcid.org/0009-0007-2550-4001"]},"institutions":[{"id":"https://openalex.org/I8975392","display_name":"Osmania University","ror":"https://ror.org/030sjb889","country_code":"IN","type":"education","lineage":["https://openalex.org/I8975392"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sailaja Gunnam","raw_affiliation_strings":["Gokaraju Rangaraju College of Pharmacy"],"raw_orcid":"https://orcid.org/0009-0007-2550-4001","affiliations":[{"raw_affiliation_string":"Gokaraju Rangaraju College of Pharmacy","institution_ids":["https://openalex.org/I8975392"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113343664","display_name":"G. Kinnera Ratna Sri","orcid":"https://orcid.org/0000-0001-9763-9174","observed_orcids":["https://orcid.org/0000-0001-9763-9174"]},"institutions":[{"id":"https://openalex.org/I8975392","display_name":"Osmania University","ror":"https://ror.org/030sjb889","country_code":"IN","type":"education","lineage":["https://openalex.org/I8975392"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"G Kinnera Ratna Sri","raw_affiliation_strings":["Gokaraju Rangaraju College of Pharmacy"],"raw_orcid":"https://orcid.org/0000-0001-9763-9174","affiliations":[{"raw_affiliation_string":"Gokaraju Rangaraju College of Pharmacy","institution_ids":["https://openalex.org/I8975392"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032650259"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"51","issue":"2","first_page":"531","last_page":"544"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.5781000256538391,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.5781000256538391,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.29589998722076416,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","score":0.10899999737739563,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tolvaptan","display_name":"tolvaptan","score":0.9950000047683716},{"id":"https://openalex.org/keywords/co-crystallization","display_name":"co-crystallization","score":0.8579999804496765},{"id":"https://openalex.org/keywords/coformers","display_name":"coformers","score":0.8799999952316284},{"id":"https://openalex.org/keywords/niacin","display_name":"nicotinic acid","score":0.9900000095367432},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7889999747276306},{"id":"https://openalex.org/keywords/water-solubility-enhancement","display_name":"aqueous solubility enhancement","score":0.875},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.8199999928474426},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7940000295639038},{"id":"https://openalex.org/keywords/tablet-formulation","display_name":"tablet formulation","score":0.6349999904632568},{"id":"https://openalex.org/keywords/crospovidone","display_name":"crospovidone","score":0.7160000205039978},{"id":"https://openalex.org/keywords/disintegrants","display_name":"disintegrants","score":0.8700000047683716},{"id":"https://openalex.org/keywords/vasopressin-v2-receptor-antagonist","display_name":"vasopressin V2 receptor antagonist","score":0.8299999833106995},{"id":"https://openalex.org/keywords/similarity-factor-f2","display_name":"similarity factor f2","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C100687433","wikidata":"https://www.wikidata.org/wiki/Q5139913","display_name":"Cocrystal","level":4,"score":0.7677000164985657},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.6995000243186951},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6223000288009644},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.5748999714851379},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.48980000615119934},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4404999911785126},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.43389999866485596},{"id":"https://openalex.org/C13530604","wikidata":"https://www.wikidata.org/wiki/Q15318","display_name":"Melting point","level":2,"score":0.41260001063346863},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.40400001406669617},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3815000057220459},{"id":"https://openalex.org/C2781060337","wikidata":"https://www.wikidata.org/wiki/Q462174","display_name":"Hydrate","level":2,"score":0.3456000089645386},{"id":"https://openalex.org/C203036418","wikidata":"https://www.wikidata.org/wiki/Q284256","display_name":"Crystallization","level":2,"score":0.3416999876499176},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.32440000772476196},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.32409998774528503},{"id":"https://openalex.org/C39519442","wikidata":"https://www.wikidata.org/wiki/Q904893","display_name":"Differential scanning calorimetry","level":2,"score":0.29829999804496765},{"id":"https://openalex.org/C185039092","wikidata":"https://www.wikidata.org/wiki/Q376044","display_name":"Powder diffraction","level":2,"score":0.2973000109195709},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.27720001339912415},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.27230000495910645},{"id":"https://openalex.org/C2776597398","wikidata":"https://www.wikidata.org/wiki/Q5954496","display_name":"Hydrazine (antidepressant)","level":2,"score":0.26600000262260437},{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.55262/fabadeczacilik.1812846","doi":"https://doi.org/10.55262/fabadeczacilik.1812846","is_oa":true,"landing_page_url":"https://doi.org/10.55262/fabadeczacilik.1812846","pdf_url":"https://dergipark.org.tr/en/download/article-file/5371759","source":{"id":"https://openalex.org/S4220650949","display_name":"Fabad Journal of Pharmaceutical Sciences","issn_l":"1300-4182","issn":["1300-4182"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fabad Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmh:oai:dergipark.org.tr:article/1812846","doi":null,"is_oa":false,"landing_page_url":"https://dergipark.org.tr/en/pub/fabadeczacilik/article/1812846","pdf_url":null,"source":{"id":"https://openalex.org/S4220650949","display_name":"Fabad Journal of Pharmaceutical Sciences","issn_l":"1300-4182","issn":["1300-4182"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fabad Eczac\u0131l\u0131k Bilimler Dergisi, Vol. 51 No. 2","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.55262/fabadeczacilik.1812846","doi":"https://doi.org/10.55262/fabadeczacilik.1812846","is_oa":true,"landing_page_url":"https://doi.org/10.55262/fabadeczacilik.1812846","pdf_url":"https://dergipark.org.tr/en/download/article-file/5371759","source":{"id":"https://openalex.org/S4220650949","display_name":"Fabad Journal of Pharmaceutical Sciences","issn_l":"1300-4182","issn":["1300-4182"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fabad Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.428600013256073,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204808590.pdf","grobid_xml":"https://content.openalex.org/works/W7204808590.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7205159443","https://openalex.org/W4414866775","https://openalex.org/W4414219289","https://openalex.org/W2601762250","https://openalex.org/W4381284493","https://openalex.org/W7221904055","https://openalex.org/W7214909365","https://openalex.org/W2939925857","https://openalex.org/W2988404588","https://openalex.org/W4385828554"],"abstract_inverted_index":{"Tolvaptan":[0,53],"(TLN),":[1],"a":[2,22,79],"vasopressin":[3],"V2":[4],"receptor":[5],"antagonist,":[6],"is":[7],"limited":[8],"by":[9],"poor":[10],"aqueous":[11],"solubility":[12,28,88],"and":[13,29,37,49,61,68,89,92,110,135],"low":[14],"oral":[15],"bioavailability.":[16],"Cocrystallization":[17],"with":[18,41,101,130,154],"suitable":[19,80],"coformers":[20,44],"offers":[21],"promising":[23],"strategy":[24],"to":[25,34,45,87],"enhance":[26],"its":[27],"dissolution.":[30],"This":[31],"study":[32],"aimed":[33],"design,":[35],"characterize,":[36],"evaluate":[38],"TLN":[39],"cocrystals":[40,55,84],"GRAS":[42],"listed":[43],"improve":[46],"solubility,":[47],"dissolution,":[48],"immediate-release":[50],"tablet":[51,147],"performance.":[52],"(TLN)":[54],"were":[56,85,106],"prepared":[57],"via":[58],"solvent-drop":[59],"grinding":[60],"characterized":[62],"using":[63],"melting":[64],"point":[65],"analysis,":[66],"DSC,":[67],"PXRD.":[69],"Molecular":[70],"docking":[71],"guided":[72],"the":[73,93,114,118,131,139,157],"selection":[74],"of":[75,117,141],"nicotinic":[76,94],"acid":[77,95,152],"as":[78,156],"coformer.":[81],"The":[82,104,145],"synthesized":[83],"subjected":[86],"dissolution":[90,115],"studies,":[91,112],"cocrystal":[96],"was":[97,121],"formulated":[98],"into":[99],"tablets":[100],"various":[102],"disintegrants.":[103],"formulations":[105],"evaluated":[107],"through":[108],"pre-":[109],"post-compression":[111],"while":[113],"profile":[116],"optimized":[119,146],"formulation":[120,148],"analyzed":[122],"in":[123,128],"terms":[124],"similarity":[125],"factor":[126],"(f2)":[127],"comparison":[129],"marketed":[132],"tablet.":[133],"DSC":[134],"PXRD":[136],"analyses":[137],"confirmed":[138],"formation":[140],"new":[142],"crystalline":[143],"phases.":[144],"(F4,":[149],"2:3":[150],"TLN-to-nicotinic":[151],"ratio":[153],"crospovidone":[155],"disintegrant)":[158],"exhibited":[159],"rapid":[160],"disintegration":[161],"(":[162]},"counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-09-01T00:00:00"}